Navigation Links
Three In One Ultrasound Probe For 3-D Imaging Of Heart And Tissue Destruction Developed

Engineers at the Duke University are working on a technology that may someday enable physicians to use high frequency ultrasound waves both to visualize the heart's interior in three dimensions and then selectively destroy heart tissue with heat to correct arrhythmias.//

This is the first time a three in one attempt has been made regarding 3-D imaging, ultrasound and therapy. The researchers believe that the technique may revolutionize the most widely used method for destroying or ‘ablating’ heart tissue that is responsible for irregular heart rhythm.

The dual-function imaging-plus-ablation ultrasound probes as small as three millimeters. As many as 200 tiny cables have been fitted into a 3 mm catheter due to the advancement in cable technology. The ablation beam emerging from the 112-transducer array is 50 times more energetic than the imaging beam.

"The nice thing about ultrasound ablation is that you don't have to touch the tissue. The sound waves propagate through the blood and can ablate the tissue from a distance of a centimeter or two", according to the engineers who have developed the technique.

The current available technique for the purpose is based on radio waves emitted from the end an electrode probe. The radio waves destruct the desired tissue upon contact by the production of excessive heat. Moreover the fluoroscopic imaging used to locate the device produces a very poor quality image, often with a fuzzy background.

The engineers have previously pioneered techniques rendering the kind of soft tissue internal images that enable fetuses to be seen in the womb. They have also pioneered the use of ultrasound to create 3-D images of the heart and other organs.

During the past five years several tiny internal ultrasound-imaging probes have been developed that offer a significant advantage over X- rays. The acquisition of only two-dimensional images by these probes limits the use of the probe for tissue ablation.

Further miniaturization and extensive design work will be necessary to build a device small enough to be inserted through vascular pathways into real hearts for visualization and ablation trials.


'"/>




Related medicine news :

1. One in Three Heart Attack Patients Have No Chest Pains
2. Nobel Prize for Medicine shared by Three scientists
3. Three Tropical Parasites Genetic Code Unravelled
4. The Future Pattern Of Weight Gain Is Laid As Early As Three Years Of Age
5. Smoking Increases The Risk Of Heart Disease By Three Times
6. Three Sisters Have One Baby and Make History
7. Three More Bird Flu Cases Reported By China
8. Three meals daily Keeps Keralas elderly Healthy
9. Three dimensional structure of apolipoprotein revealed
10. Delhi Witnessed 34 Meningitis Deaths In Three Months
11. Drug Courts In Europe Extended For Three More Years
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/21/2017)... , ... April 21, 2017 , ... ... it’s been named Agency of Record (AOR) for Theravent, Inc. , the ... snoring. Theravent’s parent company, Foundation Consumer Healthcare, is now working to expand distribution ...
(Date:4/21/2017)... ... April 21, 2017 , ... Crossover ... O2X , an active lifestyle company that provides Human Performance Training and ... firefighters, police offers, first responders, military officers and others in service through the ...
(Date:4/21/2017)... , ... April 21, 2017 , ... Alive for ... who wish to overcome their mental health struggles. The Alive team uses advanced ... says: “Our approach in dealing with a mental health struggle is based on ...
(Date:4/21/2017)... ... 21, 2017 , ... Northern California Medical Associates ... Symposium on April 1, 2017 in Santa Rosa. This well-attended annual conference plays ... an opportunity to learn about cutting edge treatments, to collaborate, share research and ...
(Date:4/21/2017)... ... April 21, 2017 , ... ... practices, is seeking candidates to serve on its Accreditation and Standards Committees ... “RadSite’s ultimate mission is improving image quality and reducing patient radiation dose,” ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 20, 2017  AbbVie (NYSE: ABBV), a global ... of chronic hepatitis C virus (HCV) infected patients ... and compensated cirrhosis (Child-Pugh A) achieved sustained virologic ... with its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). ... following 12 weeks of G/P treatment without ribavirin. ...
(Date:4/19/2017)... Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) (the "Company"), announces that it ... 2017 at the Sheraton Hotel in Toronto, Ontario ... the Company is scheduled to present on Tuesday, May 2 at ... Chairman of the Board, Tony Holler will also attend ... For more details ...
(Date:4/19/2017)... April 19, 2017 Global Prostate Cancer ... on the prostate cancer therapeutics market analyzes the ... Increasing prevalence of prostate cancer, launch of promising ... development of new drugs & therapeutic biological products, ... due to lesser side effects are some of ...
Breaking Medicine Technology: